The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease
Open accessAbstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that destroys patient memory and cognition, communication ability with the social environment and the ability to carry out daily activities. Despite extensive research into the pathogenesis of AD, a neuroprotective treatment - particularly for the early stages of disease - remains unavailable for clinical use. In this review, we advance the suggestion that lipoic acid (LA) may fulfil this therapeutic need. A naturally occurring cofactor for the mitochondrial enzymes pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, LA has been shown to have a variety of properties which can interfere with the pathogenesis or progression of AD. For example, LA increases acetylcholine (ACh) production by activation of choline acetyltransferase and increases glucose uptake, thus supplying more acetyl-CoA for the production of ACh. LA chelates redox-active transition metals, thus inhibiting the formation of hydroxyl radicals and also scavenges reactive oxygen species (ROS), thereby increasing the levels of reduced glutathione. In addition, LA down-regulates the expression of redox-sensitive pro-inflammatory proteins including TNF and inducible nitric oxide synthase. Furthermore, LA can scavenge lipid peroxidation products such as hydroxynonenal and acrolein. In human plasma, LA exists in an equilibrium of free and plasma protein bound form. Up to 150 muM, it is bound completely, most likely binding to high affinity fatty acid sites on human serum albumin, suggesting that one large dose rather than continuous low doses (as provided by "slow release" LA) will be beneficial for delivery of LA to the brain. Evidence for a clinical benefit for LA in dementia is yet limited. There are only two published studies, in which 600 mg LA was given daily to 43 patients with AD (receiving a standard treatment with choline-esterase inhibitors) in an open-label study over an observation period of up to 48 months. Whereas the improvement in patients with moderate dementia was not significant, the disease progressed extremely slowly (change in ADAScog: 1.2 points=year, MMSE: -0.6 points=year) in patients with mild dementia (ADAScog<15). Data from cell culture and animal models suggest that LA could be combined with nutraceuticals such as curcumin, (-)-epigallocatechin gallate (from green tea) and docosahexaenoic acid (from fish oil) to synergistically decrease oxidative stress, inflammation, Abeta levels and Abeta plaque load and thus provide a combined benefit in the treatment of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Potential Synergy of Phytochemicals in Cancer Prevention: Mechanism of Action
Liu, R. H. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.12.3479s · Cited by 2,276
Alpha-lipoic acid as a biological antioxidant
Packer, L., Witt, E. H., & Tritschler, H. J. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)00017-r · Cited by 1,979
Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530
Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., & Schneider, J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.940 · Cited by 1,135
Huang, X., Atwood, C. S., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J., Moir, R. D., et al. (1999) · Biochemistry · doi:10.1021/bi990438f · Cited by 1,107
Lukiw, W. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25420 · Cited by 872
Lander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17810 · Cited by 813
Suh, J. H., Shenvi, S. V., Dixon, B. M., Liu, H., Jaiswal, A. K., Liu, R.-M., & Hagen, T. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400282101 · Cited by 772
Rezai-Zadeh, K., Shytle, D., Sun, N., Mori, T., Hou, H., Jeanniton, D., Ehrhart, J., Townsend, K., Zeng, J., Morgan, D., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1521-05.2005 · Cited by 713
Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model
Calon, F., Lim, G. P., Yang, F., Morihara, T., Teter, B., Ubeda, O., Rostaing, P., Triller, A., Salem, N., Ashe, K. H., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.013 · Cited by 707
Lim, G. P., Calon, F., Morihara, T., Yang, F., Teter, B., Ubeda, O., Salem, N., Frautschy, S. A., & Cole, G. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4225-04.2005 · Cited by 686
Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease
Söderberg, M., Edlund, C., Kristensson, K., & Dallner, G. (1991) · Lipids · doi:10.1007/bf02536067 · Cited by 667
T. Griffin, W. S., Sheng, J. G., Roberts, G. W., & Mrak, R. E. (1995) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199503000-00014 · Cited by 549
Fruit and Vegetable Juices and Alzheimer’s Disease: The Kame Project
Dai, Q., Borenstein, A. R., Wu, Y., Jackson, J. C., & Larson, E. B. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.045 · Cited by 529
Conquer, J. A., Tierney, M. C., Zecevic, J., Bettger, W. J., & Fisher, R. H. (2000) · Lipids · doi:10.1007/s11745-000-0646-3 · Cited by 524
Fish, meat, and risk of dementia: cohort study
Barberger-Gateau, P. (2002) · BMJ · doi:10.1136/bmj.325.7370.932 · Cited by 486
The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress
Nguyen, T., Yang, C. S., & Pickett, C. B. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.033 · Cited by 459
Farr, S. A., Poon, H. F., Dogrukol‐Ak, D., Drake, J., Banks, W. A., Eyerman, E., Butterfield, D. A., & Morley, J. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01580.x · Cited by 459
Regional Membrane Phospholipid Alterations in Alzheimer's Disease
Prasad, M. R., Lovell, M. A., Yatin, M., Dhillon, H., & Markesbery, W. R. (1998) · Neurochemical Research · doi:10.1023/a:1022457605436 · Cited by 439
Watson, G. S., & Craft, S. (2003) · CNS Drugs · doi:10.2165/00023210-200317010-00003 · Cited by 397
Chen, X.-L., & Kunsch, C. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043452901 · Cited by 386
Mandel, S., Weinreb, O., Amit, T., & Youdim, M. B. H. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02291.x · Cited by 377
Levites, Y., Amit, T., Mandel, S., & Youdim, M. B. H. (2003) · The FASEB Journal · doi:10.1096/fj.02-0881fje · Cited by 373
Antioxidant flavonols and coronary heart disease risk
Hertog, M. G., Feskens, E. J., & Kromhout, D. (1997) · The Lancet · doi:10.1016/s0140-6736(05)60135-3 · Cited by 371
Bierhaus, A., Chevion, S., Chevion, M., Hofmann, M., Quehenberger, P., Illmer, T., Luther, T., Berentshtein, E., Tritschler, H., Müller, M., et al. (1997) · Diabetes · doi:10.2337/diab.46.9.1481 · Cited by 371
Nordberg, A., & Winblad, B. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90629-4 · Cited by 361
Curry Consumption and Cognitive Function in the Elderly
Ng, T.-P., Chiam, P.-C., Lee, T., Chua, H.-C., Lim, L., & Kua, E.-H. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj267 · Cited by 353
Choi, Y.-T., Jung, C.-H., Lee, S.-R., Bae, J.-H., Baek, W.-K., Suh, M.-H., Park, J., Park, C.-W., & Suh, S.-I. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01438-2 · Cited by 342
Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals
Zhao, B., Li, X., He, R., Cheng, S., & Wenjuan, X. (1989) · Cell Biophysics · doi:10.1007/bf02797132 · Cited by 322
Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case–control study
Tully, A. M., Roche, H. M., Doyle, R., Fallon, C., Bruce, I., Lawlor, B., Coakley, D., & Gibney, M. J. (2003) · British Journal of Nutrition · doi:10.1079/bjn2002804 · Cited by 309
Münch, G., Schinzel, R., Loske, C., Wong, A., Durany, N., Li, J. J., Vlassara, H., Smith, M. A., Perry, G., & Riederer, P. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050069 · Cited by 304
Self-citationHAGEN, T. M., INGERSOLL, R. T., LYKKESFELDT, J., LIU, J., WEHR, C. M., VINARSKY, V., BARTHOLOMEW, J. C., & AMES, B. N. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.2.411 · Cited by 291
Hashimoto, M., Tanabe, Y., Fujii, Y., Kikuta, T., Shibata, H., & Shido, O. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.3.549 · Cited by 288
Lipoic acid as a novel treatment for Alzheimer's disease and related dementias
Holmquist, L., Stuchbury, G., Berbaum, K., Muscat, S., Young, S., Hager, K., Engel, J., & Münch, G. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.07.001 · Cited by 288
Self-citationLiu, J., Killilea, D. W., & Ames, B. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261709098 · Cited by 266
Craft, S., Asthana, S., Cook, D. G., Baker, L. D., Cherrier, M., Purganan, K., Wait, C., Petrova, A., Latendresse, S., Watson, G. S., et al. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00087-2 · Cited by 255
Calon, F., Lim, G. P., Morihara, T., Yang, F., Ubeda, O., Salem, N., Frautschy, S. A., & Cole, G. M. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04253.x · Cited by 243
The role of diet in cognitive decline
Solfrizzi, V., Panza, F., & Capurso, A. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0766-8 · Cited by 237
Functional foods, herbs and nutraceuticals: towards biochemical mechanisms of healthy aging
Ferrari, C. K. B. (2004) · Biogerontology · doi:10.1007/s10522-004-2566-z · Cited by 227
Biochemical pharmacology of functional foods and prevention of chronic diseases of aging
Ferrari, C. K. B., & Torres, E. A. F. S. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(03)00032-5 · Cited by 211
Alpha-lipoic acid as a new treatment option for Azheimer type dementia
Hager, K., Marahrens, A., Kenklies, M., Riederer, P., & Münch, G. (2001) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(01)00104-2 · Cited by 188
Self-citationα-Lipoic acid as a new treatment option for Alzheimer’s disease — a 48 months follow-up analysis
Häger, K., Kenklies, M., McAfoose, J., Engel, J., & Münch, G. W. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_24 · Cited by 169
Self-citationWong, A., Lüth, H.-J., Deuther-Conrad, W., Dukic-Stefanovic, S., Gasic-Milenkovic, J., Arendt, T., & Münch, G. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02872-4 · Cited by 160
Self-citationChronic dietary α-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice
Quinn, J. F., Bussiere, J. R., Hammond, R. S., Montine, T. J., Henson, E., Jones, R. E., & Stackman, R. W. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.12.014 · Cited by 160
Lipoic acid in multiple sclerosis: a pilot study
Yadav, V., Marracci, G., Lovera, J. F., Woodward, W. R., Bogardus, K., Marquardt, W. E., Shinto, L. H., Morris, C. D., & BOURDETTE, D. N. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1143oa · Cited by 154
Suh, J. H., Wang, H., Liu, R.-M., Liu, J., & Hagen, T. M. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.12.020 · Cited by 150
Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid‐β oligomers
Florent‐Béchard, S., Malaplate, C., Youssef, I., Kriem, B., Koziel, V., Escanyé, M., Fifre, A., Sponne, I., Leininger‐Muller, B., Olivier, J. L., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03541.x · Cited by 145
Thioctic Acid for Patients with Symptomatic Diabetic Polyneuropathy: A Critical Review
Ziegler, D. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403030-00005 · Cited by 135
Zhang, L., Xing, G. Q., Barker, J. L., Chang, Y. H., Maric, D., Ma, W., Li, B., & Rubinow, D. R. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02205-4 · Cited by 128
Alzheimer?s associated inflammation, potential drug targets and future therapies
Stuchbury, G., & M�nch, G. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0188-x · Cited by 127
Self-citationFree radicals in Alzheimer’s disease
Retz, W., Gsell, W., Münch, G. W., Rösler, M., & Riederer, P. F. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-7508-8_22 · Cited by 125
Self-citationCole, G. M., & Frautschy, S. A. (2006) · Nutrition and Health · doi:10.1177/026010600601800307 · Cited by 125
Wong, A. O., Dukić-Stefanović, S., Gasic‐Milenkovic, J., Schinzel, R., Wiesinger, H., Riederer, P., & Münch, G. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01820.x · Cited by 117
Self-citationSuh, J. H., Moreau, R. F., Heath, S.-H. D., & Hagen, T. M. (2005) · Redox Report · doi:10.1179/135100005x21624 · Cited by 113
Hermann, R., Niebch, G., Borbe, H. O., Fieger-Büschges, H., Ruus, P., Nowak, H., Riethmüller-Winzen, H., Peukert, M., & Blume, H. H. (1996) · European Journal of Pharmaceutical Sciences · doi:10.1016/0928-0987(95)00045-3 · Cited by 112
Acrolein inhibits NADH-linked mitochondrial enzyme activity: Implications for Alzheimer's disease
Pocernich, C. B., & Butterfield, D. A. (2003) · Neurotoxicity Research · doi:10.1007/bf03033161 · Cited by 111
The molecular basis of the prevention of Alzheimer’s disease through healthy nutrition
Steele, M. L., Stuchbury, G., & Münch, G. W. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.06.002 · Cited by 110
Self-citationBreithaupt‐Grögler, K., Niebch, G., Schneider, E. M., Erb, K. A., Hermann, R., Blume, H. H., Schug, B. S., & Belz, G. G. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(98)00061-x · Cited by 98
Treatment of Alzheimer's disease: current and future therapeutic approaches.
Cummings, J. L. (2004) · PubMed · Cited by 94
Protection against amyloid beta peptide and iron/hydrogen peroxide toxicity by alpha lipoic acid
Lovell, M. A., Xie, C., Xiong, S., & Markesbery, W. R. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5306 · Cited by 92
Maclean, C. H., Issa, A. M., Newberry, S. J., Mojica, W., Morton, S. C., Garland, R. H., Hilton, L., Traina, S., & Shekelle, P. (2005) · PubMed · Cited by 91
Carlson, D. A., SMITH, A. R. W., Fischer, S. J., Young, K. L., & Packer, L. (2007) · PubMed · Cited by 89
Self-citationMüller, U., & Krieglstein, J. (1995) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1995.77 · Cited by 84
Memory Function and Brain Glucose Metabolism
Hoyer, S. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-40452 · Cited by 81
Shanmugam, K., Holmquist, L., Steele, M. L., Stuchbury, G., Berbaum, K., Schulz, O., García, O. B., Castillo, J., Burnell, J. N., Garcia‐Rivas, V., et al. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700180 · Cited by 74
Self-citationSuh, J. H., Zhu, B., deSzoeke, E., Frei, B. B., & Hagen, T. M. (2004) · Redox Report · doi:10.1179/135100004225003923 · Cited by 58
Cao, Z., Tsang, M., Hai, Z., & Li, Y. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.110 · Cited by 56
Fonte, J., Miklossy, J., Atwood, C., & Martins, R. N. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3206 · Cited by 49
Self-citationα-lipoic Acid Mitigates Insulin Resistance in Goto-Kakizaki Rats
Bitar, M. S., Wahid, S., Pilcher, C. W., Al-Saleh, E., & Al-Mulla, F. (2004) · Hormone and Metabolic Research · doi:10.1055/s-2004-825760 · Cited by 48
CHEN, J., Jiang, W., Cai, J., Tao, W.-Q., Gao, X., & JIANG, X. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.07.038 · Cited by 48
Effect of ?-α-lipoic acid on glutathione metabolic enzymes in aged rats
Arivazhagan, P., Ramanathan, K., & Panneerselvam, C. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00147-4 · Cited by 47
The isomers of thioctic acid alter 14C-deoxyglucose incorporation in rat basal ganglia
Seaton, T. A., Jenner, P. G., & MARSDEN, C. D. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02250-3 · Cited by 33
PET is better than perfusion SPECT for early diagnosis of Alzheimer’s disease
Ishii, K., & Minoshima, S. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1936-3 · Cited by 28
Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile
Nordberg, A. K., Nyberg, P., Adolfsson, R., & Winblad, B. G. (1987) · Journal of Neural Transmission · doi:10.1007/bf01244094 · Cited by 22
Regulation of the activity of choline acetyl transferase by lipoic acid
Haugaard, N., Levin, R. M., & Surname, F. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007156732662 · Cited by 20
Activation of choline acetyl transferase by dihydrolipoic acid
Haugaard, N., & Levin, R. M. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1017924628110 · Cited by 11
Cited by
Metals, oxidative stress and neurodegenerative disorders
Jomova, K., Vondrakova, D., Lawson, M., & Valko, M. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0563-x · Cited by 1,052
New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?
Fardet, A. (2010) · Nutrition Research Reviews · doi:10.1017/s0954422410000041 · Cited by 1,030
Therapeutics of Alzheimer's disease: Past, present and future
Anand, R., Gill, K. D., & Mahdi, A. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.004 · Cited by 747
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672
Molecular Mechanisms of Acrolein Toxicity: Relevance to Human Disease
Moghe, A., Ghare, S., Lamoreau, B., Mohammad, M., Barve, S., McClain, C., & Joshi-Barve, S. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfu233 · Cited by 511
Metadata
- Authors
- Maczurek, A., Hager, K., Kenklies, M., Sharman, M., Martins, R., Engel, J., Carlson, D. A., & Münch, G.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2008-10
- Volume
- 60
- Issue
- 13-14
- Pages
- 1463-1470
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2139911439
- Cited by
- 346
- References
- 78
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.